What is prenatal testing, and why is it crucial for women above 35

There was a time when pregnancy tests did not merely announce impending parenthood. They opened the door to nine months of low-grade anxiety dressed up as “monitoring”. Particularly if you happened to be one of the unfortunate souls told, in hushed clinical tones, that your screening was “abnormal”.Medicine, for years, handled prenatal uncertainty rather like an overenthusiastic aunt at a family wedding. Loud warnings, partial information, and enough panic to make perfectly sensible people spiral into midnight internet searches and catastrophic imagination. Then arrived NIPS. Let us understand what it is and why is it crucial for women above 35. Non-Invasive Prenatal Screening — sounding faintly like an acronym invented by consultants but quietly becoming one of the most significant shifts in prenatal care in decades. The brilliance of NIPS lies partly in its simplicity. No dramatic needles. No elaborate hospital stays. Just a blood sample drawn from the mother as early as ten weeks into pregnancy. Inside that blood float tiny fragments of fetal DNA, which laboratories analyse for chromosomal abnormalities like Down syndrome, Edwards syndrome, and Patau syndrome. Now here’s where the science stops sounding like science fiction and starts sounding like common sense finally catching up with medicine. Traditional prenatal blood screening could detect around 81% of Down syndrome cases, often accompanied by enough false positives to send half the city into unnecessary emotional cardiac arrest. NIPS, meanwhile, boasts detection rates exceeding 99% for Down syndrome, with similarly impressive accuracy for other major chromosomal conditions. Its false positive rate hovers around a tiny 0.1%. Which matters enormously because behind every false alarm lies a very real human cost. Sleepless nights. Families quietly unravelling. Women pushed towards invasive procedures like amniocentesis and CVS — tests that, while medically valuable, still carry a small but frightening risk of miscarriage.NIPS has dramatically reduced the need for those procedures. Meaning fewer women are subjected to avoidable physical risk simply because older screening systems cast far too wide and nervous a net.But before we crown modern genomics the messiah of maternal medicine, here comes the necessary reality check. NIPS is still a screening tool, not a final diagnosis. In other words, it is exceptionally good at spotting red flags, but not omniscient. Standard NIPS can miss microdeletions — tiny missing pieces of chromosomes associated with conditions like DiGeorge syndrome. It may not reliably identify subtle genetic duplications, mosaic abnormalities, or structural defects such as neural tube disorders. Biology, maddeningly, still likes keeping secrets. Which is where newer genomic technologies are stepping in with the confidence of a seasoned detective entering Act Two. Companies like Progenics are expanding prenatal diagnostics beyond broad probability into something far more precise. Their advanced M-NIPS testing looks specifically for microdeletion syndromes that standard screening often overlooks. But when a screening test flags a concern, the pathway shifts from probabilistic assessment to definitive diagnosis — and that requires direct sampling. Procedures like chorionic villus sampling (CVS) and amniocentesis collect fetal or placental tissue so diagnostic tests such as CMA, FISH, or targeted sequencing can be run on the actual fetal DNA. Those confirmatory tests turn screening signals into concrete answers, guiding counseling, clinical decisions, and timely emotional and medical planning.Tests like Chromosomal Microarray Analysis, or CMA, examines the genome at molecular resolution, detecting tiny genetic imbalances invisible under traditional microscopic testing. And then there is FISH testing. A wonderfully unfortunate acronym for something parents desperately need — speed. While comprehensive genomic results may take up to two weeks, FISH can provide rapid preliminary answers within 48 to 72 hours. In prenatal medicine, time is not merely medical. It is emotional survival. Yet perhaps the most reassuring shift in all this is not technological but human. Because every result lands not in a laboratory but in somebody’s life. Beside nursery plans, family hopes, nervous fathers pretending not to panic, and mothers trying to stay calm while carrying both a child and impossible uncertainty. Which is why genetic counselling has become as important as the testing itself. Platforms like AskEVO, Progenics’ AI-assisted counselling support system backed by certified and qualified genetic counsellors, now help families understand complex results in plain language while ensuring access to human counsellors when empathy matters more than algorithms. And really, that is the heart of such tests. Not that medicine has become smarter. We expect that now. It is that prenatal care, for once, is finally learning how to be gentler while delivering the truth.Contributed by: Dr. Surakasi Venkata Prasad, CEO